CBD Compliance Documentation for Healthcare Providers

Healthcare providers, ACO administrators, and physicians need to know exactly what they're recommending to patients. At Edify Wellness, we understand the regulatory pressures and documentation requirements that come with recommending cannabidiol products. Whether you're evaluating CBD for your Accountable Care Organization or advising individual patients, our complete compliance documentation gives you the confidence that every product meets federal standards and third-party testing requirements. Learn more about how CBD fits into your patient care model by reviewing our Medicare CBD program guide, which explains eligibility, coverage considerations, and product selection for your population.

Why Edify for Your ACO

Choosing a CBD supplier means choosing a partner you can trust. Edify Wellness stands apart because we own and operate a USDA organic certified family farm in Kentucky, giving us complete control over hemp quality from seed to finished product. Our Seed-to-Self traceability system means you can track every product back to its original plant material. We don't work through middlemen or resellers. Our nano-enhanced bioavailability technology means patients can achieve therapeutic results at lower doses, making your $500 Substance Access BEI allocation stretch further. Every batch undergoes independent third-party laboratory testing with results available to the public. We use only plant-based, vegan formulations with zero synthetic cannabinoids or artificial additives. And because we sell direct from the farm, you get wholesale pricing that respects your budget constraints while maintaining premium quality.

Certificates of Analysis (COAs) and Lab Testing

A complete Certificate of Analysis confirms potency, verifies pesticide absence, tests for heavy metals, and screens for microbial contaminants. This is non-negotiable for any healthcare provider recommending CBD to patients. Edify's third-party tested products come with detailed COAs covering all four critical areas. You'll find every lab result at our public lab results page, where you can review potency data, pesticide screening results, heavy metals testing, and microbial analysis for all our products. Our testing partner uses ISO/IEC 17025 accredited methods, meaning results are reproducible and defensible. For your ACO's compliance file, these documents provide clear evidence that recommended products meet all federal safety standards. No product leaves our facility without passing independent lab verification.

USDA Organic Certification

USDA organic certification isn't just a marketing claim. It's verification that our hemp was grown without synthetic pesticides, artificial fertilizers, or prohibited substances. For healthcare providers recommending products to vulnerable populations, organic status matters. Our Kentucky family farm holds current USDA organic certification, audited annually by an independent certifying body. This certification covers soil quality, water usage, pest management practices, and every input that touches our crop. When you recommend an Edify product, you can confidently tell patients that their CBD comes from organically grown hemp. For details on our certification status and farm practices, visit our USDA organic certification page.

Hemp Source and Traceability

Where does your CBD actually come from? Many suppliers can't answer this question. Edify can, because we grow our own hemp on our Kentucky family farm. Our Seed-to-Self program tracks every product from seed genetics through growing season, harvest, processing, testing, and final formulation. This traceability means no mystery ingredients, no unknown growing practices, and no questions about supply chain integrity. You can review our complete traceability system at our Seed-to-Self transparency page. For ACO medical directors and compliance officers, this level of documentation support means you can answer patient questions about product origins with confidence. Every product is Kentucky hemp grown on our certified organic farm.

THC Verification and Compliance

Federal law permits hemp-derived CBD products containing no more than 0.3 percent delta-9 THC by dry weight. The Substance Access BEI program requires products to contain 3mg or less total THC per serving. Edify's products meet both standards. Every batch is independently tested and results are publicly available. Our lab testing specifically confirms that delta-9 THC content stays well below the federal 0.3 percent threshold and that total THC per serving does not exceed 3mg. This verification appears on every COA and becomes part of your compliance documentation. When healthcare providers and ACO administrators recommend Edify products, they're recommending products that meet all federal THC restrictions.

Substance Access BEI Program Compliance Table

Use this table to verify that Edify CBD products meet all Substance Access BEI program requirements:

BEI Requirement	Edify Compliance
Oral administration only	Yes. Gummies and tinctures (taken by mouth)
Hemp-derived	Yes. Kentucky-grown hemp, Seed-to-Self
0.3% or less delta-9 THC	Yes. Every batch tested and verified
3mg or less total THC per serving	Yes. Lab results confirm compliance
Third-party tested	Yes. Independent lab testing with public COAs
No inhalable products	Correct. All qualifying products are oral
No synthetic cannabinoids	Correct. All-natural, plant-based formulations

Compliant Product Options for Your ACO

Edify offers several BEI-compliant products designed for healthcare settings. Sleep CBD Gummies support restorative rest without inhalation or synthetic ingredients. Soothe Recovery CBD Gummies address discomfort management for patients with joint or muscular concerns. Joy CBD Gummies deliver mood support through hemp-derived cannabinoids. Relieve THC-Free Tincture provides CBD combined with CBG for patients requiring zero THC. Relieve Full Spectrum offers a complete cannabinoid profile within BEI compliance limits. All products are vegan, plant-based, and contain no synthetic cannabinoids or artificial additives. Nano-enhanced formulations mean patients can often achieve results at lower doses, maximizing the value of their $500 annual BEI allocation.

Getting Your ACO Set Up with Edify

Ready to add Edify CBD products to your ACO's approved medication list? Our wholesale program offers volume pricing, bulk ordering, and compliance support tailored to your organization's needs. We provide sample products, complete COAs, USDA organic documentation, traceability records, and all other materials your medical director and compliance team need to evaluate and approve products. To request a wholesale quote and discuss your ACO's specific requirements, visit our wholesale CBD quote page. Our team works directly with healthcare organizations to ensure smooth integration, competitive pricing, and ongoing documentation support.

Documentation for Your Files

Every compliance file needs to include COAs, third-party testing results, ingredient lists, and supplier information. Edify provides all of this material in standardized formats ready for your records. We maintain current USDA organic certification, pass annual audits, and keep all lab testing documentation publicly accessible. Our compliance team can provide additional documentation as needed for your accreditation body, state healthcare agencies, or internal audit requirements. We understand that healthcare providers face serious documentation obligations, and we're built to support them.

For questions about compliance documentation, product selection for your population, or ACO wholesale pricing, contact the Edify Wellness team directly. We're here to ensure your organization has everything needed to recommend CBD products with full confidence in their safety, quality, and regulatory compliance.

Shop Edify CBD & Wellness Products

Written by the Edify Wellness Team